Acumen Pharmaceuticals, Inc. (ABOS)

NASDAQ: ABOS · IEX Real-Time Price · USD
3.84
+0.01 (0.26%)
At close: Dec 29, 2023, 4:00 PM
3.77
-0.07 (-1.82%)
After-hours: Dec 29, 2023, 7:19 PM EST

Total Valuation

ABOS has a market cap or net worth of $222.38 million. The enterprise value is $6.76 million.

Market Cap 222.38M
Enterprise Value 6.76M

Important Dates

The last earnings date was Monday, November 13, 2023, before market open.

Earnings Date Nov 13, 2023
Ex-Dividend Date n/a

Share Statistics

ABOS has 57.91 million shares outstanding. The number of shares has increased by 33.89% in one year.

Shares Outstanding 57.91M
Shares Change (YoY) +33.89%
Shares Change (QoQ) +32.19%
Owned by Insiders (%) 8.16%
Owned by Institutions (%) 83.38%
Float 30.59M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.79
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 35.85, with a Debt / Equity ratio of 0.00.

Current Ratio 35.85
Quick Ratio n/a
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -23.90% and return on invested capital (ROIC) is -20.30%.

Return on Equity (ROE) -23.90%
Return on Assets (ROA) -23.00%
Return on Capital (ROIC) -20.30%
Revenue Per Employee n/a
Profits Per Employee -$1.25M
Employee Count 39
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -28.49% in the last 52 weeks. The beta is -0.37, so ABOS's price volatility has been lower than the market average.

Beta (1Y) -0.37
52-Week Price Change -28.49%
50-Day Moving Average 2.68
200-Day Moving Average 4.61
Relative Strength Index (RSI) 74.80
Average Volume (30 Days) 537,258

Short Selling Information

The latest short interest is 609,564, so 1.05% of the outstanding shares have been sold short.

Short Interest 609,564
Short Previous Month 538,295
Short % of Shares Out 1.05%
Short % of Float 1.99%
Short Ratio (days to cover) 1.19

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -56.90M
Pretax Income -48.74M
Net Income -48.74M
EBITDA -48.55M
EBIT -48.74M
Earnings Per Share (EPS) -$1.12
Full Income Statement

Balance Sheet

The company has $215.62 million in cash and $2,000 in debt, giving a net cash position of $215.62 million or $3.72 per share.

Cash & Cash Equivalents 215.62M
Total Debt 2,000
Net Cash 215.62M
Net Cash Per Share $3.72
Equity / Book Value 280.27M
Book Value Per Share 4.84
Working Capital 212.50M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$45.95 million and capital expenditures -$39,000, giving a free cash flow of -$45.99 million.

Operating Cash Flow -45.95M
Capital Expenditures -39,000
Free Cash Flow -45.99M
FCF Per Share -$0.85
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ABOS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -21.92%
FCF Yield -20.68%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -33.89%
Shareholder Yield -33.89%

Analyst Forecast

The average price target for ABOS is $12.60, which is 228.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.60
Price Target Difference 228.13%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) 4.97%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2